Comparison 29. Sensitivity analysis 9, random effects meta‐analysis.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
29.1 Rate of falls ‐ cholinesterase inhibitor vs placebo	3	248	Rate Ratio (IV, Random, 95% CI)	0.50 [0.43, 0.58]
29.1.1 Rivastigmine vs placebo	2	210	Rate Ratio (IV, Random, 95% CI)	0.48 [0.35, 0.66]
29.1.2 Donepezil vs placebo	1	38	Rate Ratio (IV, Random, 95% CI)	0.52 [0.44, 0.62]
29.2 Number of fallers ‐ cholinesterase inhibitor vs placebo	3	249	Risk Ratio (IV, Random, 95% CI)	0.95 [0.70, 1.28]
29.2.1 Rivastigmine vs placebo	2	211	Risk Ratio (IV, Random, 95% CI)	0.61 [0.20, 1.90]
29.2.2 Donepezil vs placebo	1	38	Risk Ratio (IV, Random, 95% CI)	1.13 [0.90, 1.40]